CD274 and neoplasm: To further define changes in the CD8+ T cell population that may contribute to the enhanced tumor responses observed by the addition of AZD1390 to radiation and anti–PD-L1, we compared differentially expressed genes between CD8+ T cells treated with AZD1390 versus without in combination with radiation and anti–PD-L1.